HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scleral patch grafts in the management of uveal and ocular surface tumors.

AbstractOBJECTIVE:
To evaluate the outcome of scleral patch grafts in a series of patients undergoing management for uveal and ocular surface tumors.
DESIGN:
Case series.
PARTICIPANTS:
Ten patients underwent scleral patch grafting. Five patients had uveal melanoma with extrascleral extension, 2 patients had scleromalacia secondary to plaque radiotherapy for uveal melanoma, 2 patients had suspicious uveoscleral nevi, and 1 patient had invasive conjunctival squamous cell carcinoma with scleral necrosis.
METHODS:
Retrospective, interventional, noncomparative chart review of patients undergoing treatment for ocular tumors followed by scleral grafts in a tertiary eye care center in the United States between September 2003 and January 2011. Sclera was reconstructed with allogenic scleral grafts. Clinical observations were performed after grafting.
MAIN OUTCOME MEASURES:
Structural integrity, appearance, and stability of the grafts.
RESULTS:
Ten patients were reviewed. All melanoma cases received plaque radiotherapy with palladium 103. The cases with nevi and squamous cell carcinoma underwent local resection with cryotherapy as primary treatment. In 8 cases, scleral grafting was performed as part of the initial surgery. In all of these cases, satisfactory anatomic and functional outcomes were achieved. In 2 cases with scleromalacia secondary to radiotherapy for uveal melanoma, grafts were placed several years after the initial treatment. In these 2 cases, one showed signs of graft retraction, whereas another showed graft thinning. No patients experienced graft infection, rejection, or tumor recurrence.
CONCLUSIONS:
In this series, scleral grafts were well accepted when placed as part of the primary tumor management despite synchronous radiotherapy, scleral resection, or cryotherapy. Grafting was less successful when performed as a late procedure for radiation-induced scleromalacia.
FINANCIAL DISCLOSURE(S):
The author(s) have no proprietary or commercial interest in any materials discussed in this article.
AuthorsManabjyoti Barman, Paul T Finger, Tatyana Milman
JournalOphthalmology (Ophthalmology) Vol. 119 Issue 12 Pg. 2631-6 (Dec 2012) ISSN: 1549-4713 [Electronic] United States
PMID22858126 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Radioisotopes
  • Palladium
Topics
  • Adult
  • Aged
  • Brachytherapy (adverse effects)
  • Carcinoma, Squamous Cell (pathology, surgery)
  • Combined Modality Therapy
  • Conjunctival Neoplasms (pathology, surgery)
  • Cryotherapy
  • Female
  • Free Tissue Flaps
  • Humans
  • Male
  • Melanoma (pathology, radiotherapy, surgery)
  • Middle Aged
  • Neoplasm Invasiveness
  • Nevus, Pigmented (pathology, surgery)
  • Ophthalmologic Surgical Procedures
  • Palladium (therapeutic use)
  • Radiation Injuries (etiology, pathology, surgery)
  • Radioisotopes (therapeutic use)
  • Retrospective Studies
  • Sclera (transplantation)
  • Scleral Diseases (etiology, pathology, surgery)
  • Transplantation, Homologous
  • Uveal Neoplasms (pathology, radiotherapy, surgery)
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: